Catalog4 refs
HGH Fragment 176-191
MetabolicMetabolic & Weight LossFat Loss PeptideWeight LossResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
Skin
Overview
HGH Fragment 176-191 is a stabilized piece of human growth hormone (amino acids 176-191) and the parent compound of AOD-9604. Research focuses on fat breakdown without the growth-promoting or blood sugar effects of full growth hormone. It stimulates lipolysis and fat oxidation through a GH-receptor-independent mechanism, targeting adipose tissue without affecting IGF-1, glucose metabolism, or growth.
Primary Uses
Stimulates lipolysis and fat oxidation
Promotes fat oxidation and release of free fatty acids from adipocytes
Targets stubborn visceral and abdominal fat stores
Mimics the lipolytic region of human growth hormone
Fat loss
Lipolysis enhancement
Lipogenesis inhibition
Body composition
Weight loss
Lipolysis
Protocol Reference
Dose
250-500 mcg daily (Range: 200-600 mcg daily)
Frequency
1-2x daily, fasted
Half-life
15-20 minutes
Route
Subcutaneous injection on empty stomach
Evidence
Investigational - Research ongoing / Moderate Research (disputed)
Research References· 2
https://pubmed.ncbi.nlm.nih.gov/11673763/
PubMedPMID 11673763- [https://www.jofem.org/index.php/jofem/article/view/157/194](https://www.jofem.org/index.php/jofem/article/view/157/194)
Research Models
HumanMouse
Also in Metabolic